Table 1.
CRISPR-tools.
Type | Advantages | Disadvantages | Applied in primary T cells | Ref |
---|---|---|---|---|
Lentiviral | Inclusion of selection marker | Low knock-out efficacy Genomic integration |
Yes | [76], [77] |
Electroporation | T cells retain expansion potential Extensive protocols are available |
Cytotoxic Costly | Yes | [48], [73], [89], [90], [91] |
(Lipid) nanoparticles | Highly adaptable to specific need | Complex to engineer | No | [84], [85] |
Ligand fusion tags | Cell-type specific | Cells need to express receptor | No | [83] |
Cell-penetrating peptides | Produced in-house | Varying quality and efficacy due to batch-to-batch differences | No | [86], [87], [88] |